I’ve helped develop treatments for major depressive disorder, primarily monoamine reuptake inhibitors, but most recently for postpartum depression with novel mechanisms of action, including allopregnanolone analogs, psychedelics, specifically psilocybin and kappa opioid receptor antagonists. —Anita Clayton, MD, Professor and Chair, Department of Psychiatry and Neurobehavioral Sciences
To watch more Research in Motion videos in this series:
- Visit our School of Medicine website research landing page
- Sign-up for our weekly newsletter Medicine in Motion or the SOM’s YouTube channel
The post Research in Motion: Anita Clayton, MD appeared first on Medicine in Motion News.